Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Mark S, Patterson"'
Autor:
Pascal Christiaan Jan Visser, Maarten A Vink, Mark S Patterson, Aria Yazdanbakhsh, Fatih Arlan, Remko S Kuipers
Publikováno v:
BMJ case reports. 15(4)
A 31-year-old man with a history of hypertrophic cardiomyopathy and alcohol septal ablation one week before was presented after an out of hospital cardiac arrest in the setting of an anterior wall ST-elevation myocardial infarction. Immediate coronar
Autor:
Thomas Oomens, Nicola S. Vos, René J. van der Schaaf, Giovanni Amoroso, Mark M. Ewing, Mark S. Patterson, Jean-Paul R. Herrman, Ton Slagboom, Maarten A. Vink
Publikováno v:
International Journal of Cardiology.
Autor:
Maarten A. Vink, Freek W.A. Verheugt, Ton Slagboom, Robert K. Riezebos, Robbert J. de Winter, Jean-Paul R. Herrman, Nicola S. Vos, Jan G.P. Tijssen, Erik F. J. Oosterwerff, Giovanni Amoroso, Nick D. Fagel, Mark S. Patterson, René J. van der Schaaf
Publikováno v:
American heart journal, 234, 42-50. Mosby Inc.
Background: In intermediate- and high-risk non-ST elevated acute coronary syndrome (NSTE-ACS) patients, a routine invasive approach is recommended. The timing of coronary angiography remains controversial. To assess whether an immediate (
Autor:
Sander R, Niehe, Nicola S, Vos, René J, Van Der Schaaf, Giovanni, Amoroso, Jean-Paul R, Herrman, Mark S, Patterson, Ton, Slagboom, Maarten A, Vink
Publikováno v:
The Journal of invasive cardiology. 34(1)
The randomized REVELATION (REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION) trial showed that in the setting of ST-segment elevation myocardial infarction (STEMI), a drug-coated
Autor:
Nicola S. Vos, Nick D. Fagel, Robert K. Riezebos, Jean-Paul R. Herrman, Tanja Rabbering, Ton Slagboom, Giovanni Amoroso, René J. van der Schaaf, Mark S. Patterson, Froukje Gescher, Robbert J. de Winter, Eva C. Verbeek, Maarten A. Vink
Publikováno v:
Catheterization and cardiovascular interventions, 98(5), E661-E667. Wiley-Liss Inc.
Objectives: We aimed to explore the impact of time to percutaneous coronary intervention (PCI) (T2P) on 1-year mortality in non-ST-elevation myocardial infarction (NSTEMI) patients. Background: The current guidelines recommend an early invasive strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b574e054ea2659ec4991f2a156bbad
https://pure.amc.nl/en/publications/oneyear-mortality-in-nstemi-patients-is-unaffected-by-timing-of-pci-within-the-first-week-of-admission-results-of-a-realworld-cohort-analysis(6027308c-eb95-4920-b254-ade4c9e1d28f).html
https://pure.amc.nl/en/publications/oneyear-mortality-in-nstemi-patients-is-unaffected-by-timing-of-pci-within-the-first-week-of-admission-results-of-a-realworld-cohort-analysis(6027308c-eb95-4920-b254-ade4c9e1d28f).html
Autor:
Nicola S. Vos, Lieuwe H. Piers, Jean-Paul R. Herrman, Maarten A. Vink, Ton Slagboom, Mark S. Patterson, Nick D. Fagel, Giovanni Amoroso, René J. van der Schaaf
Publikováno v:
JACC: Cardiovascular Interventions. 12:1691-1699
Objectives This study sought to assess the efficacy and safety of a drug-coated balloon (DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI). Background In
Autor:
Giovanni Amoroso, M. Maarse, Ton Slagboom, Mark S. Patterson, Nick D. Fagel, M. J. Suttorp, J. P. Herrman, F. C. van Nooijen, GertJan Laarman, R J van der Schaaf, Maarten A. Vink
Publikováno v:
Netherlands heart journal, 27(6), 310-320. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal
Objectives/background: In patients with multivessel coronary artery disease (MVD) the decision whether to treat a single culprit vessel or to perform multivessel revascularisation may be challenging. The purpose of this study was to evaluate the long
Autor:
Nicola S, Vos, Nick D, Fagel, Giovanni, Amoroso, Jean-Paul R, Herrman, Mark S, Patterson, Lieuwe H, Piers, René J, van der Schaaf, Ton, Slagboom, Maarten A, Vink
Publikováno v:
JACC. Cardiovascular interventions. 12(17)
This study sought to assess the efficacy and safety of a drug-coated balloon (DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI).In primary percutaneous c
Autor:
Nicola S, Vos, Giovanni, Amoroso, Maarten A, Vink, Moniek, Maarse, Rob, Adams, Jean-Pau R, Herrman, Mark S, Patterson, Renè J, van der Schaaf, Ton, Slagboom, Robbert J, de Winter
Publikováno v:
The Journal of invasive cardiology. 30(12)
Pretreatment with P2Y12 inhibitors before primary percutaneous coronary intervention (PPCI) can reduce the incidence of major adverse cardiovascular event (MACE) rate in ST-segment elevation myocardial infarction (STEMI) patients. We investigated dif
Autor:
Jean-Paul R. Herrman, Ton Slagboom, Maarten A. Vink, Nicola S. Vos, Giovanni Amoroso, Mark S. Patterson, René J. van der Schaaf
Publikováno v:
Catheterization and Cardiovascular Interventions. 87:1213-1221
Aim In primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI), stenting has proved to reduce the need for repeat revascularization compared with balloon angioplasty alone. The incidence of cardiac death or re